{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:18:36Z","timestamp":1793330316252,"version":"4.5.0"},"reference-count":194,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T00:00:00Z","timestamp":1524182400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1038\/nrrheum.2018.48","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T01:15:43Z","timestamp":1524186943000},"page":"255-268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":164,"title":["Risk factors and disease mechanisms in myositis"],"prefix":"10.1038","volume":"14","author":[{"given":"Frederick W.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine A.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanneboyina","family":"Nagaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,20]]},"reference":[{"key":"BFnrrheum201848_CR1","unstructured":"Lundberg, I. E., de Visser, M. & Werth, V. P. Classification of myositis. Nat. Rev. Rheumatol. https:\/\/doi.org\/nrrheum.2018.41 (2018)."},{"key":"BFnrrheum201848_CR2","unstructured":"Rider, L. G. et al. Update on outcome assessment in myositis. Nat. Rev. Rheumatol. https:\/\/doi.org\/nrrheum.2018.33 (2018)."},{"key":"BFnrrheum201848_CR3","doi-asserted-by":"publisher","unstructured":"McHugh, N.J. & Tansley, S.L. Autoantibodies in myositis Nat. Rev. Rheumatol. https:\/\/doi.org\/10.1038\/nrrheum.2018.56 (2018).","DOI":"10.1038\/nrrheum.2018.56"},{"key":"BFnrrheum201848_CR4","doi-asserted-by":"publisher","unstructured":"Oddis, C. V. & Aggarwal, R. Treatment in myositis. Nat. Rev. Rheumatol. https:\/\/doi.org\/10.1038\/nrrheum.2018.42 (2018).","DOI":"10.1038\/nrrheum.2018.42"},{"key":"BFnrrheum201848_CR5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3109\/14397595.2013.844299","volume":"24","author":"T Ozaki","year":"2014","unstructured":"Ozaki, T. et al. Two patients in the same family with anti-ARS antibody-associated myositis. Mod. Rheumatol. 24, 699\u2013700 (2014).","journal-title":"Mod. Rheumatol."},{"key":"BFnrrheum201848_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/1529-0131(199804)41:4<710::AID-ART19>3.0.CO;2-K","volume":"41","author":"LG Rider","year":"1998","unstructured":"Rider, L. G. et al. Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy. Arthritis Rheum. 41, 710\u2013719 (1998).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR7","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.2337\/diabetes.52.4.1052","volume":"52","author":"V Hyttinen","year":"2003","unstructured":"Hyttinen, V., Kaprio, J., Kinnunen, L., Koskenvuo, M. & Tuomilehto, J. Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes 52, 1052\u20131055 (2003).","journal-title":"Diabetes"},{"key":"BFnrrheum201848_CR8","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/art.24385","volume":"60","author":"D van der Woude","year":"2009","unstructured":"van der Woude, D. et al. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. Arthritis Rheum. 60, 916\u2013923 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR9","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/1529-0131(199803)41:3<400::AID-ART4>3.0.CO;2-5","volume":"41","author":"LR Ginn","year":"1998","unstructured":"Ginn, L. R. et al. Familial autoimmunity in pedigrees of idiopathic inflammatory myopathy patients suggests common genetic risk factors for many autoimmune diseases. Arthritis Rheum. 41, 400\u2013405 (1998).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR10","doi-asserted-by":"publisher","first-page":"e1239","DOI":"10.1542\/peds.2010-3022","volume":"127","author":"TB Niewold","year":"2011","unstructured":"Niewold, T. B., Wu, S. C., Smith, M., Morgan, G. A. & Pachman, L. M. Familial aggregation of autoimmune disease in juvenile dermatomyositis. Pediatrics 127, e1239\u2013e1246 (2011).","journal-title":"Pediatrics"},{"key":"BFnrrheum201848_CR11","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1001\/jamainternmed.2015.3528","volume":"175","author":"CF Kuo","year":"2015","unstructured":"Kuo, C. F. et al. Familial aggregation of systemic lupus erythematosus and coaggregation of autoimmune diseases in affected families. JAMA Intern. Med. 175, 1518\u20131526 (2015).","journal-title":"JAMA Intern. Med."},{"key":"BFnrrheum201848_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13075-016-1127-6","volume":"18","author":"CF Kuo","year":"2016","unstructured":"Kuo, C. F. et al. Familial risk of systemic sclerosis and co-aggregation of autoimmune diseases in affected families. Arthritis Res. Ther. 18, 231 (2016).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum201848_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","volume":"54","author":"A Meyer","year":"2015","unstructured":"Meyer, A. et al. Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology 54, 50\u201363 (2015).","journal-title":"Rheumatology"},{"key":"BFnrrheum201848_CR14","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1002\/art.38137","volume":"65","author":"FW Miller","year":"2013","unstructured":"Miller, F. W. et al. Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders. Arthritis Rheum. 65, 3239\u20133247 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR15","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/gene.2015.28","volume":"16","author":"FW Miller","year":"2015","unstructured":"Miller, F. W. et al. Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes. Genes Immun. 16, 470\u2013480 (2015).","journal-title":"Genes Immun."},{"key":"BFnrrheum201848_CR16","doi-asserted-by":"publisher","first-page":"e64683","DOI":"10.1371\/journal.pone.0064683","volume":"8","author":"X Jia","year":"2013","unstructured":"Jia, X. et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS ONE 8, e64683 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrrheum201848_CR17","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1136\/annrheumdis-2015-208119","volume":"75","author":"S Rothwell","year":"2016","unstructured":"Rothwell, S. et al. Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups. Ann. Rheum. Dis. 75, 1558\u20131566 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201848_CR18","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1002\/art.40045","volume":"69","author":"S Rothwell","year":"2017","unstructured":"Rothwell, S. et al. Immune-array analysis in sporadic inclusion body myositis reveals HLA-DRB1 amino acid heterogeneity across the myositis spectrum. Arthritis Rheumatol. 69, 1090\u20131099 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum201848_CR19","first-page":"1768","volume":"31","author":"T Furuya","year":"2004","unstructured":"Furuya, T. et al. Immunogenetic features in 120 Japanese patients with idiopathic inflammatory myopathy. J. Rheumatol. 31, 1768\u20131774 (2004).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201848_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-5945-14-9","volume":"14","author":"X Gao","year":"2014","unstructured":"Gao, X. et al. HLA class II alleles may influence susceptibility to adult dermatomyositis and polymyositis in a Han Chinese population. BMC Dermatol. 14, 9 (2014).","journal-title":"BMC Dermatol."},{"key":"BFnrrheum201848_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/01.md.0000217525.82287.eb","volume":"85","author":"TP O'Hanlon","year":"2006","unstructured":"O'Hanlon, T. P. et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine 85, 111\u2013127 (2006).","journal-title":"Medicine"},{"key":"BFnrrheum201848_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11926-009-0040-2","volume":"11","author":"TP O'Hanlon","year":"2009","unstructured":"O'Hanlon, T. P. & Miller, F. W. Genetic risk and protective factors for the idiopathic inflammatory myopathies. Curr. Rheumatol. Rep. 11, 287\u2013294 (2009).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnrrheum201848_CR23","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/acr.20662","volume":"64","author":"AL Mammen","year":"2012","unstructured":"Mammen, A. L. et al. Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Arthritis Care Res. 64, 1233\u20131237 (2012).","journal-title":"Arthritis Care Res."},{"key":"BFnrrheum201848_CR24","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/acr.23113","volume":"69","author":"T Kishi","year":"2017","unstructured":"Kishi, T. et al. Association of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies with DRB1*07:01 and severe myositis in juvenile myositis patients. Arthritis Care Res. 69, 1088\u20131094 (2017).","journal-title":"Arthritis Care Res."},{"key":"BFnrrheum201848_CR25","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1002\/art.23900","volume":"58","author":"H Chinoy","year":"2008","unstructured":"Chinoy, H. et al. The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients. Arthritis Rheum. 58, 3247\u20133254 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR26","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1136\/annrheumdis-2011-200839","volume":"71","author":"T Sugiura","year":"2012","unstructured":"Sugiura, T. et al. Positive association between STAT4 polymorphisms and polymyositis\/dermatomyositis in a Japanese population. Ann. Rheum. Dis. 71, 1646\u20131650 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201848_CR27","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s12026-015-8738-x","volume":"64","author":"Q Wang","year":"2016","unstructured":"Wang, Q. et al. Positive association of genetic variations in the phospholipase C-like 1 gene with dermatomyositis in Chinese Han. Immunol. Res. 64, 204\u2013212 (2016).","journal-title":"Immunol. Res."},{"key":"BFnrrheum201848_CR28","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1136\/annrheumdis-2015-207762","volume":"75","author":"KE Lintner","year":"2016","unstructured":"Lintner, K. E. et al. Gene copy-number variations (CNVs) of complement C4 and C4A deficiency in genetic risk and pathogenesis of juvenile dermatomyositis. Ann. Rheum. Dis. 75, 1599\u20131606 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201848_CR29","doi-asserted-by":"publisher","first-page":"218.e1","DOI":"10.1016\/j.neurobiolaging.2016.07.024","volume":"47","author":"Q Gang","year":"2016","unstructured":"Gang, Q. et al. Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis. Neurobiol. Aging 47, 218.e1\u2013218.e9 (2016).","journal-title":"Neurobiol. Aging"},{"key":"BFnrrheum201848_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.nmd.2014.12.009","volume":"25","author":"CC Weihl","year":"2015","unstructured":"Weihl, C. C. et al. Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis. Neuromuscul. Disord. 25, 289\u2013296 (2015).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrrheum201848_CR31","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ana.24847","volume":"81","author":"AK Guttsches","year":"2017","unstructured":"Guttsches, A. K. et al. Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis. Ann. Neurol. 81, 227\u2013239 (2017).","journal-title":"Ann. Neurol."},{"key":"BFnrrheum201848_CR32","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/BOR.0000000000000328","volume":"28","author":"S Rothwell","year":"2016","unstructured":"Rothwell, S., Lamb, J. A. & Chinoy, H. New developments in genetics of myositis. Curr. Opin. Rheumatol. 28, 651\u2013656 (2016).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum201848_CR33","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3389\/fimmu.2017.00927","volume":"8","author":"A Torrelo","year":"2017","unstructured":"Torrelo, A. CANDLE syndrome as a paradigm of proteasome-related autoinflammation. Front. Immunol. 8, 927 (2017).","journal-title":"Front. Immunol."},{"key":"BFnrrheum201848_CR34","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S1074-7613(01)00201-1","volume":"15","author":"EK Wakeland","year":"2001","unstructured":"Wakeland, E. K., Liu, K., Graham, R. R. & Behrens, T. W. Delineating the genetic basis of systemic lupus erythematosus. Immunity 15, 397\u2013408 (2001).","journal-title":"Immunity"},{"key":"BFnrrheum201848_CR35","doi-asserted-by":"publisher","first-page":"e57304","DOI":"10.1371\/journal.pone.0057304","volume":"8","author":"AJ Svendsen","year":"2013","unstructured":"Svendsen, A. J. et al. On the origin of rheumatoid arthritis: the impact of environment and genes \u2014 a population based twin study. PLoS ONE 8, e57304 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrrheum201848_CR36","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1097\/00002281-199305060-00004","volume":"5","author":"LA Love","year":"1993","unstructured":"Love, L. A. & Miller, F. W. Noninfectious environmental agents associated with myopathies. Curr. Opin. Rheumatol. 5, 712\u2013718 (1993).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum201848_CR37","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0889-857X(02)00029-7","volume":"28","author":"AM Reed","year":"2002","unstructured":"Reed, A. M. & Ytterberg, S. R. Genetic and environmental risk factors for idiopathic inflammatory myopathies. Rheum. Dis. Clin. North Am. 28, 891\u2013916 (2002).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"BFnrrheum201848_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/B978-012595961-2\/50026-3","volume-title":"The Autoimmune Diseases","author":"FW Miller","year":"2006","unstructured":"Miller, F. W. in The Autoimmune Diseases Vol. 4 (eds Rose, N. R. & Mackay, I. R.) 297\u2013308 (Elsevier, 2006)."},{"key":"BFnrrheum201848_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/1529-0131(200002)43:2<243::AID-ANR2>3.0.CO;2-K","volume":"43","author":"FW Miller","year":"2000","unstructured":"Miller, F. W. et al. Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum. 43, 243\u2013249 (2000).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jaut.2012.05.001","volume":"39","author":"FW Miller","year":"2012","unstructured":"Miller, F. W. et al. Criteria for environmentally associated autoimmune diseases. J. Autoimmun. 39, 253\u2013258 (2012).","journal-title":"J. Autoimmun."},{"key":"BFnrrheum201848_CR41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/pedi.12232","volume":"17","author":"S Fazeli Farsani","year":"2016","unstructured":"Fazeli Farsani, S. et al. Increasing trends in the incidence and prevalence rates of type 1 diabetes among children and adolescents in the Netherlands. Pediatr. Diabetes 17, 44\u201352 (2016).","journal-title":"Pediatr. Diabetes"},{"key":"BFnrrheum201848_CR42","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMra020100","volume":"347","author":"JF Bach","year":"2002","unstructured":"Bach, J. F. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347, 911\u2013920 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum201848_CR43","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/art.1780341108","volume":"34","author":"RL Leff","year":"1991","unstructured":"Leff, R. L. et al. Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies. Arthritis Rheum. 34, 1391\u20131396 (1991).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/bmj.38301.686030.63","volume":"330","author":"CJ Willer","year":"2005","unstructured":"Willer, C. J. et al. Timing of birth and risk of multiple sclerosis: population based study. BMJ 330, 120 (2005).","journal-title":"BMJ"},{"key":"BFnrrheum201848_CR45","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1002\/art.21198","volume":"52","author":"K Sarkar","year":"2005","unstructured":"Sarkar, K. et al. Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups. Arthritis Rheum. 52, 2433\u20132438 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR46","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1002\/art.22751","volume":"56","author":"LJ Vegosen","year":"2007","unstructured":"Vegosen, L. J. et al. Seasonal birth patterns in myositis subgroups suggest an etiologic role of early environmental exposures. Arthritis Rheum. 56, 2719\u20132728 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1006\/smim.1997.0100","volume":"10","author":"NR Rose","year":"1998","unstructured":"Rose, N. R. The role of infection in the pathogenesis of autoimmune disease. Semin. Immunol. 10, 5\u201313 (1998).","journal-title":"Semin. Immunol."},{"key":"BFnrrheum201848_CR48","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1046\/j.1365-3083.1997.d01-145.x","volume":"46","author":"MB Oldstone","year":"1997","unstructured":"Oldstone, M. B. Viruses and autoimmune diseases. Scand. J. Immunol. 46, 320\u2013325 (1997).","journal-title":"Scand. J. Immunol."},{"key":"BFnrrheum201848_CR49","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jaut.2012.05.020","volume":"39","author":"D Germolec","year":"2012","unstructured":"Germolec, D., Kono, D. H., Pfau, J. C. & Pollard, K. M. Animal models used to examine the role of the environment in the development of autoimmune disease: findings from an NIEHS Expert Panel Workshop. J. Autoimmun. 39, 285\u2013293 (2012).","journal-title":"J. Autoimmun."},{"key":"BFnrrheum201848_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-1-4419-8216-2_6","volume":"711","author":"FW Miller","year":"2011","unstructured":"Miller, F. W. Environmental agents and autoimmune diseases. Adv. Exp. Med. Biol. 711, 61\u201381 (2011).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFnrrheum201848_CR51","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.tig.2012.10.006","volume":"29","author":"JC Knight","year":"2013","unstructured":"Knight, J. C. Genomic modulators of the immune response. Trends Genet. 29, 74\u201383 (2013).","journal-title":"Trends Genet."},{"key":"BFnrrheum201848_CR52","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2014.12.020","volume":"160","author":"P Brodin","year":"2015","unstructured":"Brodin, P. et al. Variation in the human immune system is largely driven by non-heritable influences. Cell 160, 37\u201347 (2015).","journal-title":"Cell"},{"key":"BFnrrheum201848_CR53","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/ncprheum0435","volume":"3","author":"M Gourley","year":"2007","unstructured":"Gourley, M. & Miller, F. W. Mechanisms of disease: environmental factors in the pathogenesis of rheumatic disease. Nat. Clin. Pract. Rheumatol. 3, 172\u2013180 (2007).","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"BFnrrheum201848_CR54","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jaut.2012.05.002","volume":"39","author":"FW Miller","year":"2012","unstructured":"Miller, F. W. et al. Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J. Autoimmun. 39, 259\u2013271 (2012).","journal-title":"J. Autoimmun."},{"key":"BFnrrheum201848_CR55","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1093\/rheumatology\/kex162","volume":"56","author":"G Mamyrova","year":"2017","unstructured":"Mamyrova, G. et al. Environmental factors associated with disease flare in juvenile and adult dermatomyositis. Rheumatology 56, 1342\u20131347 (2017).","journal-title":"Rheumatology"},{"key":"BFnrrheum201848_CR56","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.rdc.2014.07.003","volume":"40","author":"VM Holers","year":"2014","unstructured":"Holers, V. M. Insights from populations at risk for the future development of classified rheumatoid arthritis. Rheum. Dis. Clin. North Am. 40, 605\u2013620 (2014).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"BFnrrheum201848_CR57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-60327-827-0_2","volume-title":"Inflammatory Myopathies","author":"FW Miller","year":"2009","unstructured":"Miller, F. W. in Inflammatory Myopathies (ed. Kagen, L.) 15\u201328 (Humana Press, 2009)."},{"key":"BFnrrheum201848_CR58","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/BOR.0b013e32834b5457","volume":"23","author":"L Gan","year":"2011","unstructured":"Gan, L. & Miller, F. W. State of the art: what we know about infectious agents and myositis. Curr. Opin. Rheumatol. 23, 585\u2013594 (2011).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum201848_CR59","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1002\/art.30514","volume":"63","author":"JA Allen","year":"2011","unstructured":"Allen, J. A. et al. Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan. Arthritis Rheum. 63, 3633\u20133639 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR60","doi-asserted-by":"publisher","first-page":"920","DOI":"10.7326\/0003-4819-118-12-199306150-00002","volume":"118","author":"J Cukier","year":"1993","unstructured":"Cukier, J. et al. Association between bovine collagen dermal implants and a dermatomyositis or a polymyositis-like syndrome. Ann. Intern. Med. 118, 920\u2013928 (1993).","journal-title":"Ann. Intern. Med."},{"key":"BFnrrheum201848_CR61","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1002\/art.20587","volume":"50","author":"T O'Hanlon","year":"2004","unstructured":"O'Hanlon, T. et al. Immunogenetic differences between Caucasian women with and those without silicone implants in whom myositis develops. Arthritis Rheum. 50, 3646\u20133650 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR62","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/art.37985","volume":"65","author":"M Shah","year":"2013","unstructured":"Shah, M., Targoff, I. N., Rice, M. M., Miller, F. W. & Rider, L. G. Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis. Arthritis Rheum. 65, 1934\u20131941 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR63","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/art.24702","volume":"60","author":"LA Love","year":"2009","unstructured":"Love, L. A. et al. Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. Arthritis Rheum. 60, 2499\u20132504 (2009).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR64","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/art.39059","volume":"67","author":"MP Webber","year":"2015","unstructured":"Webber, M. P. et al. Nested case\u2013control study of selected systemic autoimmune diseases in World Trade Center rescue\/recovery workers. Arthritis Rheumatol. 67, 1369\u20131376 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum201848_CR65","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10067-013-2467-0","volume":"33","author":"A Labirua-Iturburu","year":"2014","unstructured":"Labirua-Iturburu, A. et al. Occupational exposure in patients with the antisynthetase syndrome. Clin. Rheumatol. 33, 221\u2013225 (2014).","journal-title":"Clin. Rheumatol."},{"key":"BFnrrheum201848_CR66","first-page":"86","volume":"18","author":"T Nojima","year":"2000","unstructured":"Nojima, T. et al. A case of polymyositis associated with hepatitis B infection. Clin. Exp. Rheumatol. 18, 86\u201388 (2000).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum201848_CR67","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.2169\/internalmedicine.56.7595","volume":"56","author":"JW Chou","year":"2017","unstructured":"Chou, J. W., Lin, Y. L., Cheng, K. S., Wu, P. Y. & Reanne Ju, T. Dermatomyositis induced by hepatitis B virus-related hepatocellular carcinoma: a case report and review of the literature. Intern. Med. 56, 1831\u20131837 (2017).","journal-title":"Intern. Med."},{"key":"BFnrrheum201848_CR68","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1212\/WNL.0000000000002291","volume":"86","author":"A Uruha","year":"2016","unstructured":"Uruha, A. et al. Hepatitis C virus infection in inclusion body myositis: a case-control study. Neurology 86, 211\u2013217 (2016).","journal-title":"Neurology"},{"key":"BFnrrheum201848_CR69","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/art.11002","volume":"49","author":"RW Johnson","year":"2003","unstructured":"Johnson, R. W., Williams, F. M., Kazi, S., Dimachkie, M. M. & Reveille, J. D. Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome. Arthritis Rheum. 49, 172\u2013178 (2003).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR70","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00296-009-1231-x","volume":"31","author":"MB Carroll","year":"2011","unstructured":"Carroll, M. B. & Holmes, R. Dermatomyositis and HIV infection: case report and review of the literature. Rheumatol. Int. 31, 673\u2013679 (2011).","journal-title":"Rheumatol. Int."},{"key":"BFnrrheum201848_CR71","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/ana.21103","volume":"61","author":"MC Dalakas","year":"2007","unstructured":"Dalakas, M. C. et al. Inclusion body myositis with human immunodeficiency virus infection: four cases with clonal expansion of viral-specific T cells. Ann. Neurol. 61, 466\u2013475 (2007).","journal-title":"Ann. Neurol."},{"key":"BFnrrheum201848_CR72","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/nen.0b013e31815f38b7","volume":"67","author":"E Matsuura","year":"2008","unstructured":"Matsuura, E. et al. Inclusion body myositis associated with human T-lymphotropic virus-type I infection: eleven patients from an endemic area in Japan. J. Neuropathol. Exp. Neurol. 67, 41\u201349 (2008).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrrheum201848_CR73","first-page":"1556","volume":"27","author":"EE Calore","year":"2000","unstructured":"Calore, E. E. et al. Skeletal muscle pathology in 2 siblings infected with Toxoplasma gondii . J. Rheumatol. 27, 1556\u20131559 (2000).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201848_CR74","first-page":"995","volume":"14","author":"GJ Carroll","year":"1987","unstructured":"Carroll, G. J., Will, R. K., Peter, J. B., Garlepp, M. J. & Dawkins, R. L. Penicillamine induced polymyositis and dermatomyositis. J. Rheumatol. 14, 995\u20131001 (1987).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201848_CR75","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1001\/archderm.144.10.1341","volume":"144","author":"AK Somani","year":"2008","unstructured":"Somani, A. K., Swick, A. R., Cooper, K. D. & McCormick, T. S. Severe dermatomyositis triggered by interferon beta-1a therapy and associated with enhanced type I interferon signaling. Arch. Dermatol. 144, 1341\u20131349 (2008).","journal-title":"Arch. Dermatol."},{"key":"BFnrrheum201848_CR76","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1001\/jamadermatol.2013.5220","volume":"149","author":"SW Liu","year":"2013","unstructured":"Liu, S. W. et al. Dermatomyositis induced by anti-tumor necrosis factor in a patient with juvenile idiopathic arthritis. JAMA Dermatol. 149, 1204\u20131208 (2013).","journal-title":"JAMA Dermatol."},{"key":"BFnrrheum201848_CR77","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/BOR.0000000000000108","volume":"26","author":"JD Jones","year":"2014","unstructured":"Jones, J. D., Kirsch, H. L., Wortmann, R. L. & Pillinger, M. H. The causes of drug-induced muscle toxicity. Curr. Opin. Rheumatol. 26, 697\u2013703 (2014).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum201848_CR78","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00296-017-3821-3","volume":"38","author":"IBP Borges","year":"2018","unstructured":"Borges, I. B. P., Silva, M. G., Misse, R. G. & Shinjo, S. K. Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review. Rheumatol. Int. 38, 293\u2013301 (2018).","journal-title":"Rheumatol. Int."},{"key":"BFnrrheum201848_CR79","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.autrev.2016.07.023","volume":"15","author":"L Musset","year":"2016","unstructured":"Musset, L. et al. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: a history of statins and experience from a large international multi-center study. Autoimmun. Rev. 15, 983\u2013993 (2016).","journal-title":"Autoimmun. Rev."},{"key":"BFnrrheum201848_CR80","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1177\/0961203309345734","volume":"18","author":"H Orbach","year":"2009","unstructured":"Orbach, H. & Tanay, A. Vaccines as a trigger for myopathies. Lupus 18, 1213\u20131216 (2009).","journal-title":"Lupus"},{"key":"BFnrrheum201848_CR81","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1136\/annrheumdis-2017-211174","volume":"76","author":"J Svensson","year":"2017","unstructured":"Svensson, J., Holmqvist, M., Lundberg, I. E. & Arkema, E. V. Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case\u2013control study. Ann. Rheum. Dis. 76, 1803\u20131808 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201848_CR82","first-page":"1218","volume":"16","author":"MG Lyon","year":"1989","unstructured":"Lyon, M. G., Bloch, D. A., Hollak, B. & Fries, J. F. Predisposing factors in polymyositis-dermatomyositis: results of a nationwide survey. J. Rheumatol. 16, 1218\u20131224 (1989).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201848_CR83","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/annrheumdis-2011-200182","volume":"71","author":"H Chinoy","year":"2012","unstructured":"Chinoy, H. et al. Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study. Ann. Rheum. Dis. 71, 961\u2013965 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201848_CR84","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1136\/annrheumdis-2016-210282","volume":"76","author":"JB Lilleker","year":"2017","unstructured":"Lilleker, J. B. et al. The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann. Rheum. Dis. 76, 862\u2013868 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201848_CR85","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/oxfordjournals.aje.a112341","volume":"104","author":"MJ Koch","year":"1976","unstructured":"Koch, M. J., Brody, J. A. & Gillespie, M. M. Childhood polymyositis: a case-control study. Am. J. Epidemiol. 104, 627\u2013631 (1976).","journal-title":"Am. J. Epidemiol."},{"key":"BFnrrheum201848_CR86","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/acr.22358","volume":"66","author":"MA Orione","year":"2014","unstructured":"Orione, M. A. et al. Risk factors for juvenile dermatomyositis: exposure to tobacco and air pollutants during pregnancy. Arthritis Care Res. 66, 1571\u20131575 (2014).","journal-title":"Arthritis Care Res."},{"key":"BFnrrheum201848_CR87","first-page":"1329","volume":"17","author":"CV Oddis","year":"1990","unstructured":"Oddis, C. V., Conte, C. G., Steen, V. D. & Medsger, T. A. Jr. Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963\u20131982. J. Rheumatol. 17, 1329\u20131334 (1990).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201848_CR88","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/clin.1997.4412","volume":"84","author":"DL Jacobson","year":"1997","unstructured":"Jacobson, D. L., Gange, S. J., Rose, N. R. & Graham, N. M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 84, 223\u2013243 (1997).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"BFnrrheum201848_CR89","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1172\/JCI118749","volume":"97","author":"N Goebels","year":"1996","unstructured":"Goebels, N. et al. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermato-myositis. J. Clin. Invest. 97, 2905\u20132910 (1996).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum201848_CR90","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0960-8966(94)90022-1","volume":"4","author":"S Orimo","year":"1994","unstructured":"Orimo, S. et al. Immunohistochemical analysis of perforin and granzyme A in inflammatory myopathies. Neuromuscul. Disord. 4, 219\u2013226 (1994).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrrheum201848_CR91","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1093\/brain\/aww024","volume":"139","author":"SA Greenberg","year":"2016","unstructured":"Greenberg, S. A., Pinkus, J. L., Amato, A. A., Kristensen, T. & Dorfman, D. M. Association of inclusion body myositis with T cell large granular lymphocytic leukaemia. Brain 139, 1348\u20131360 (2016).","journal-title":"Brain"},{"key":"BFnrrheum201848_CR92","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJM199103283241303","volume":"324","author":"R Hohlfeld","year":"1991","unstructured":"Hohlfeld, R., Engel, A. G., Ii, K. & Harper, M. C. Polymyositis mediated by T lymphocytes that express the gamma\/delta receptor. N. Engl. J. Med. 324, 877\u2013881 (1991).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum201848_CR93","doi-asserted-by":"publisher","first-page":"515","DOI":"10.4049\/jimmunol.169.1.515","volume":"169","author":"H Wiendl","year":"2002","unstructured":"Wiendl, H. et al. An autoreactive \u03b3\u03b4 TCR derived from a polymyositis lesion. J. Immunol. 169, 515\u2013521 (2002).","journal-title":"J. Immunol."},{"key":"BFnrrheum201848_CR94","doi-asserted-by":"publisher","first-page":"20986","DOI":"10.1074\/jbc.M112.356709","volume":"287","author":"J Bruder","year":"2012","unstructured":"Bruder, J. et al. Target specificity of an autoreactive pathogenic human \u03b3\u03b4-T cell receptor in myositis. J. Biol. Chem. 287, 20986\u201320995 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum201848_CR95","doi-asserted-by":"publisher","first-page":"227","DOI":"10.5692\/clinicalneurol.52.227","volume":"52","author":"T Yamashita","year":"2012","unstructured":"Yamashita, T. et al. A case of myositis associated with clonal expansion of \u03b3\u03b4 T cells in peripheral blood and bone marrow [Japanese]. Rinsho Shinkeigaku 52, 227\u2013233 (2012).","journal-title":"Rinsho Shinkeigaku"},{"key":"BFnrrheum201848_CR96","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.4049\/jimmunol.0803688","volume":"183","author":"AE Fasth","year":"2009","unstructured":"Fasth, A. E. et al. T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells. J. Immunol. 183, 4792\u20134799 (2009).","journal-title":"J. Immunol."},{"key":"BFnrrheum201848_CR97","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1002\/art.27665","volume":"62","author":"JM Pandya","year":"2010","unstructured":"Pandya, J. M. et al. Expanded T cell receptor V\u03b2-restricted T cells from patients with sporadic inclusion body myositis are proinflammatory and cytotoxic CD28null T cells. Arthritis Rheum. 62, 3457\u20133466 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR98","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1002\/art.39650","volume":"68","author":"JM Pandya","year":"2016","unstructured":"Pandya, J. M. et al. CD4+ and CD8+ CD28null T cells are cytotoxic to autologous muscle cells in patients with polymyositis. Arthritis Rheumatol. 68, 2016\u20132026 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrrheum201848_CR99","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jneuroim.2010.03.013","volume":"225","author":"A Waschbisch","year":"2010","unstructured":"Waschbisch, A., Schwab, N., Ruck, T., Stenner, M. P. & Wiendl, H. FOXP3+ T regulatory cells in idiopathic inflammatory myopathies. J. Neuroimmunol. 225, 137\u2013142 (2010).","journal-title":"J. Neuroimmunol."},{"key":"BFnrrheum201848_CR100","doi-asserted-by":"publisher","first-page":"e105353","DOI":"10.1371\/journal.pone.0105353","volume":"9","author":"Y Vercoulen","year":"2014","unstructured":"Vercoulen, Y. et al. Increased presence of FOXP3+ regulatory T cells in inflamed muscle of patients with active juvenile dermatomyositis compared to peripheral blood. PLoS ONE 9, e105353 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrrheum201848_CR101","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cell.2013.10.054","volume":"155","author":"D Burzyn","year":"2013","unstructured":"Burzyn, D. et al. A special population of regulatory T cells potentiates muscle repair. Cell 155, 1282\u20131295 (2013).","journal-title":"Cell"},{"key":"BFnrrheum201848_CR102","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1212\/01.wnl.0000187124.92826.20","volume":"65","author":"SA Greenberg","year":"2005","unstructured":"Greenberg, S. A. et al. Plasma cells in muscle in inclusion body myositis and polymyositis. Neurology 65, 1782\u20131787 (2005).","journal-title":"Neurology"},{"key":"BFnrrheum201848_CR103","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1212\/WNL.59.8.1170","volume":"59","author":"SA Greenberg","year":"2002","unstructured":"Greenberg, S. A. et al. Molecular profiles of inflammatory myopathies. Neurology 59, 1170\u20131182 (2002).","journal-title":"Neurology"},{"key":"BFnrrheum201848_CR104","doi-asserted-by":"publisher","first-page":"547","DOI":"10.4049\/jimmunol.178.1.547","volume":"178","author":"EM Bradshaw","year":"2007","unstructured":"Bradshaw, E. M. et al. A local antigen-driven humoral response is present in the inflammatory myopathies. J. Immunol. 178, 547\u2013556 (2007).","journal-title":"J. Immunol."},{"key":"BFnrrheum201848_CR105","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/rheumatology\/kep078","volume":"48","author":"H Gunawardena","year":"2009","unstructured":"Gunawardena, H., Betteridge, Z. E. & McHugh, N. J. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology 48, 607\u2013612 (2009).","journal-title":"Rheumatology"},{"key":"BFnrrheum201848_CR106","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/joim.12451","volume":"280","author":"Z Betteridge","year":"2016","unstructured":"Betteridge, Z. & McHugh, N. Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J. Intern. Med. 280, 8\u201323 (2016).","journal-title":"J. Intern. Med."},{"key":"BFnrrheum201848_CR107","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1093\/rheumatology\/kev444","volume":"55","author":"R Aggarwal","year":"2016","unstructured":"Aggarwal, R. et al. Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab. Rheumatology 55, 991\u2013999 (2016).","journal-title":"Rheumatology"},{"key":"BFnrrheum201848_CR108","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jaut.2007.07.005","volume":"29","author":"Y Katsumata","year":"2007","unstructured":"Katsumata, Y. et al. Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation. J. Autoimmun. 29, 174\u2013186 (2007).","journal-title":"J. Autoimmun."},{"key":"BFnrrheum201848_CR109","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20020186","volume":"196","author":"OM Howard","year":"2002","unstructured":"Howard, O. M. et al. Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J. Exp. Med. 196, 781\u2013791 (2002).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum201848_CR110","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-074950","volume":"31","author":"M Merad","year":"2013","unstructured":"Merad, M., Sathe, P., Helft, J., Miller, J. & Mortha, A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31, 563\u2013604 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrrheum201848_CR111","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/mus.20649","volume":"35","author":"SA Greenberg","year":"2007","unstructured":"Greenberg, S. A., Pinkus, G. S., Amato, A. A. & Pinkus, J. L. Myeloid dendritic cells in inclusion-body myositis and polymyositis. Muscle Nerve 35, 17\u201323 (2007).","journal-title":"Muscle Nerve"},{"key":"BFnrrheum201848_CR112","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3899\/jrheum.120590","volume":"40","author":"H Gendek-Kubiak","year":"2013","unstructured":"Gendek-Kubiak, H. & Gendek, E. G. Fascin-expressing dendritic cells dominate in polymyositis and dermatomyositis. J. Rheumatol. 40, 186\u2013191 (2013).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum201848_CR113","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1740-2557-3-2","volume":"3","author":"K Nagaraju","year":"2006","unstructured":"Nagaraju, K. et al. Endothelial cell activation and neovascularization are prominent in dermatomyositis. J. Autoimmune Dis. 3, 2 (2006).","journal-title":"J. Autoimmune Dis."},{"key":"BFnrrheum201848_CR114","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/art.27494","volume":"62","author":"MS Maddur","year":"2010","unstructured":"Maddur, M. S. et al. Contribution of myeloid dendritic cells to type I interferon-induced cytokines and chemokines: comment on the article by Bilgic et al. Arthritis Rheum. 62, 2181\u20132182 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR115","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/mus.24642","volume":"52","author":"T Chung","year":"2015","unstructured":"Chung, T., Christopher-Stine, L., Paik, J. J., Corse, A. & Mammen, A. L. The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy. Muscle Nerve 52, 189\u2013195 (2015).","journal-title":"Muscle Nerve"},{"key":"BFnrrheum201848_CR116","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.nmd.2013.11.004","volume":"24","author":"JL Rinnenthal","year":"2014","unstructured":"Rinnenthal, J. L. et al. Inflammatory myopathy with abundant macrophages (IMAM): the immunology revisited. Neuromuscul. Disord. 24, 151\u2013155 (2014).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrrheum201848_CR117","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/cbin.10705","volume":"41","author":"X Liu","year":"2017","unstructured":"Liu, X. et al. Macrophage depletion impairs skeletal muscle regeneration: The roles of regulatory factors for muscle regeneration. Cell Biol. Int. 41, 228\u2013238 (2017).","journal-title":"Cell Biol. Int."},{"key":"BFnrrheum201848_CR118","doi-asserted-by":"publisher","first-page":"560629","DOI":"10.1155\/2014\/560629","volume":"2014","author":"E Rigamonti","year":"2014","unstructured":"Rigamonti, E., Zordan, P., Sciorati, C., Rovere-Querini, P. & Brunelli, S. Macrophage plasticity in skeletal muscle repair. Biomed. Res. Int. 2014, 560629 (2014).","journal-title":"Biomed. Res. Int."},{"key":"BFnrrheum201848_CR119","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/art.33350","volume":"64","author":"A Tournadre","year":"2012","unstructured":"Tournadre, A., Lenief, V., Eljaafari, A. & Miossec, P. Immature muscle precursors are a source of interferon-\u03b2 in myositis: role of Toll-like receptor 3 activation and contribution to HLA class I up-regulation. Arthritis Rheum. 64, 533\u2013541 (2012).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR120","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/art.27465","volume":"62","author":"A Tournadre","year":"2010","unstructured":"Tournadre, A., Lenief, V. & Miossec, P. Expression of Toll-like receptor 3 and Toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines. Arthritis Rheum. 62, 2144\u20132151 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR121","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1212\/WNL.0b013e31821f440a","volume":"76","author":"C Cappelletti","year":"2011","unstructured":"Cappelletti, C. et al. Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies. Neurology 76, 2079\u20132088 (2011).","journal-title":"Neurology"},{"key":"BFnrrheum201848_CR122","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/cei.12445","volume":"178","author":"EM Moran","year":"2014","unstructured":"Moran, E. M. & Mastaglia, F. L. Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications. Clin. Exp. Immunol. 178, 405\u2013415 (2014).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrrheum201848_CR123","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/2044-5040-3-13","volume":"3","author":"S Rayavarapu","year":"2013","unstructured":"Rayavarapu, S., Coley, W., Kinder, T. B. & Nagaraju, K. Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness. Skelet. Muscle 3, 13 (2013).","journal-title":"Skelet. Muscle"},{"key":"BFnrrheum201848_CR124","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/BOR.0b013e3283317b31","volume":"21","author":"B De Paepe","year":"2009","unstructured":"De Paepe, B., Creus, K. K. & De Bleecker, J. L. Role of cytokines and chemokines in idiopathic inflammatory myopathies. Curr. Opin. Rheumatol. 21, 610\u2013616 (2009).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum201848_CR125","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ana.20464","volume":"57","author":"SA Greenberg","year":"2005","unstructured":"Greenberg, S. A. et al. Interferon-\u03b1\/\u03b2-mediated innate immune mechanisms in dermatomyositis. Ann. Neurol. 57, 664\u2013678 (2005).","journal-title":"Ann. Neurol."},{"key":"BFnrrheum201848_CR126","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/ana.21805","volume":"67","author":"M Salajegheh","year":"2010","unstructured":"Salajegheh, M. et al. Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy. Ann. Neurol. 67, 53\u201363 (2010).","journal-title":"Ann. Neurol."},{"key":"BFnrrheum201848_CR127","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1136\/ard.2010.139949","volume":"70","author":"AP Liao","year":"2011","unstructured":"Liao, A. P. et al. Interferon \u03b2 is associated with type 1 interferon-inducible gene expression in dermatomyositis. Ann. Rheum. Dis. 70, 831\u2013836 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201848_CR128","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s11926-010-0101-6","volume":"12","author":"SA Greenberg","year":"2010","unstructured":"Greenberg, S. A. Dermatomyositis and type 1 interferons. Curr. Rheumatol. Rep. 12, 198\u2013203 (2010).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnrrheum201848_CR129","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2119\/2006-00085.Baechler","volume":"13","author":"EC Baechler","year":"2007","unstructured":"Baechler, E. C. et al. An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity. Mol. Med. 13, 59\u201368 (2007).","journal-title":"Mol. Med."},{"key":"BFnrrheum201848_CR130","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/gene.2011.61","volume":"13","author":"SA Greenberg","year":"2012","unstructured":"Greenberg, S. A. et al. Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis. Genes Immun. 13, 207\u2013213 (2012).","journal-title":"Genes Immun."},{"key":"BFnrrheum201848_CR131","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1002\/art.22928","volume":"56","author":"RJ Walsh","year":"2007","unstructured":"Walsh, R. J. et al. Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Arthritis Rheum. 56, 3784\u20133792 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR132","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1136\/ard.2010.141051","volume":"70","author":"P Krol","year":"2011","unstructured":"Krol, P. et al. Serum levels of interferon \u03b1 do not correlate with disease activity in patients with dermatomyositis\/polymyositis. Ann. Rheum. Dis. 70, 879\u2013880 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201848_CR133","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1158\/1078-0432.CCR-10-1114","volume":"17","author":"S Hervas-Stubbs","year":"2011","unstructured":"Hervas-Stubbs, S. et al. Direct effects of type I interferons on cells of the immune system. Clin. Cancer Res. 17, 2619\u20132627 (2011).","journal-title":"Clin. Cancer Res."},{"key":"BFnrrheum201848_CR134","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00401-017-1731-9","volume":"134","author":"A Meyer","year":"2017","unstructured":"Meyer, A. et al. IFN-\u03b2-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis. Acta Neuropathol. 134, 655\u2013666 (2017).","journal-title":"Acta Neuropathol."},{"key":"BFnrrheum201848_CR135","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.4049\/jimmunol.1002631","volume":"186","author":"N Akeno","year":"2011","unstructured":"Akeno, N. et al. IFN-\u03b1 mediates the development of autoimmunity both by direct tissue toxicity and through immune cell recruitment mechanisms. J. Immunol. 186, 4693\u20134706 (2011).","journal-title":"J. Immunol."},{"key":"BFnrrheum201848_CR136","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s00125-017-4536-4","volume":"61","author":"A Coomans de Brachene","year":"2018","unstructured":"Coomans de Brachene, A. et al. IFN-\u03b1 induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells. Diabetologia 61, 636\u2013640 (2018).","journal-title":"Diabetologia"},{"key":"BFnrrheum201848_CR137","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1365-2249.1995.tb02287.x","volume":"101","author":"MS Atta","year":"1995","unstructured":"Atta, M. S., Irving, W. L., Powell, R. J. & Todd, I. Enhanced expression of MHC class I molecules on cultured human thyroid follicular cells infected with reovirus through induction of type 1 interferons. Clin. Exp. Immunol. 101, 121\u2013126 (1995).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrrheum201848_CR138","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1002\/art.21103","volume":"52","author":"K Nagaraju","year":"2005","unstructured":"Nagaraju, K. et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum. 52, 1824\u20131835 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR139","doi-asserted-by":"publisher","first-page":"9209","DOI":"10.1073\/pnas.97.16.9209","volume":"97","author":"K Nagaraju","year":"2000","unstructured":"Nagaraju, K. et al. Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc. Natl Acad. Sci. USA 97, 9209\u20139214 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum201848_CR140","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/annrheumdis-2012-202794","volume":"73","author":"BW Higgs","year":"2014","unstructured":"Higgs, B. W. et al. A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-\u03b1 monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients. Ann. Rheum. Dis. 73, 256\u2013262 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201848_CR141","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/15321819.2017.1298525","volume":"38","author":"E Manole","year":"2017","unstructured":"Manole, E., Bastian, A. E., Butoianu, N. & Goebel, H. H. Myositis non-inflammatory mechanisms: an up-dated review. J. Immunoassay Immunochem. 38, 115\u2013126 (2017).","journal-title":"J. Immunoassay Immunochem."},{"key":"BFnrrheum201848_CR142","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/ar3791","volume":"14","author":"W Coley","year":"2012","unstructured":"Coley, W., Rayavarapu, S. & Nagaraju, K. Role of non-immune mechanisms of muscle damage in idiopathic inflammatory myopathies. Arthritis Res. Ther. 14, 209 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum201848_CR143","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s11926-012-0247-5","volume":"14","author":"S Rayavarapu","year":"2012","unstructured":"Rayavarapu, S., Coley, W. & Nagaraju, K. Endoplasmic reticulum stress in skeletal muscle homeostasis and disease. Curr. Rheumatol. Rep. 14, 238\u2013243 (2012).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnrrheum201848_CR144","doi-asserted-by":"publisher","first-page":"R52","DOI":"10.1186\/ar2963","volume":"12","author":"M Vitadello","year":"2010","unstructured":"Vitadello, M., Doria, A., Tarricone, E., Ghirardello, A. & Gorza, L. Myofiber stress-response in myositis: parallel investigations on patients and experimental animal models of muscle regeneration and systemic inflammation. Arthritis Res. Ther. 12, R52 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum201848_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0002-9440(10)63089-1","volume":"164","author":"G Vattemi","year":"2004","unstructured":"Vattemi, G., Engel, W. K., McFerrin, J. & Askanas, V. Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle. Am. J. Pathol. 164, 1\u20137 (2004).","journal-title":"Am. J. Pathol."},{"key":"BFnrrheum201848_CR146","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/BOR.0000000000000212","volume":"27","author":"AP Lightfoot","year":"2015","unstructured":"Lightfoot, A. P., Nagaraju, K., McArdle, A. & Cooper, R. G. Understanding the origin of non-immune cell-mediated weakness in the idiopathic inflammatory myopathies \u2013 potential role of ER stress pathways. Curr. Opin. Rheumatol. 27, 580\u2013585 (2015).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum201848_CR147","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1212\/01.WNL.0000049913.27181.51","volume":"60","author":"MC Monici","year":"2003","unstructured":"Monici, M. C., Aguennouz, M., Mazzeo, A., Messina, C. & Vita, G. Activation of nuclear factor-\u03baB in inflammatory myopathies and Duchenne muscular dystrophy. Neurology 60, 993\u2013997 (2003).","journal-title":"Neurology"},{"key":"BFnrrheum201848_CR148","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/labinvest.2016.68","volume":"96","author":"B De Paepe","year":"2016","unstructured":"De Paepe, B. et al. Activation of osmolyte pathways in inflammatory myopathy and Duchenne muscular dystrophy points to osmoregulation as a contributing pathogenic mechanism. Lab. Invest. 96, 872\u2013884 (2016).","journal-title":"Lab. Invest."},{"key":"BFnrrheum201848_CR149","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jaut.2016.08.004","volume":"75","author":"S Bhattarai","year":"2016","unstructured":"Bhattarai, S. et al. The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies. J. Autoimmun. 75, 118\u2013129 (2016).","journal-title":"J. Autoimmun."},{"key":"BFnrrheum201848_CR150","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.4103\/0366-6999.180528","volume":"129","author":"X Yin","year":"2016","unstructured":"Yin, X., Han, G. C., Jiang, X. W., Shi, Q. & Pu, C. Q. Increased expression of the NOD-like receptor family, pyrin domain containing 3 inflammasome in dermatomyositis and polymyositis is a potential contributor to their pathogenesis. Chin. Med. J. 129, 1047\u20131052 (2016).","journal-title":"Chin. Med. J."},{"key":"BFnrrheum201848_CR151","doi-asserted-by":"crossref","first-page":"66444","DOI":"10.18632\/oncotarget.12119","volume":"7","author":"HR Bae","year":"2016","unstructured":"Bae, H. R. et al. \u03b2-Hydroxybutyrate suppresses inflammasome formation by ameliorating endoplasmic reticulum stress via AMPK activation. Oncotarget 7, 66444\u201366454 (2016).","journal-title":"Oncotarget"},{"key":"BFnrrheum201848_CR152","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1006\/niox.1999.0261","volume":"3","author":"A Wanchu","year":"1999","unstructured":"Wanchu, A., Khullar, M., Sud, A. & Bambery, P. Nitric oxide production is increased in patients with inflammatory myositis. Nitric Oxide 3, 454\u2013458 (1999).","journal-title":"Nitric Oxide"},{"key":"BFnrrheum201848_CR153","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1006\/clin.1998.4527","volume":"87","author":"DS Tews","year":"1998","unstructured":"Tews, D. S. & Goebel, H. H. Cell death and oxidative damage in inflammatory myopathies. Clin. Immunol. Immunopathol. 87, 240\u2013247 (1998).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"BFnrrheum201848_CR154","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.nut.2015.04.022","volume":"31","author":"K Lambert","year":"2015","unstructured":"Lambert, K. et al. Grape polyphenols supplementation reduces muscle atrophy in a mouse model of chronic inflammation. Nutrition 31, 1275\u20131283 (2015).","journal-title":"Nutrition"},{"key":"BFnrrheum201848_CR155","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1002\/art.30530","volume":"63","author":"HM Alger","year":"2011","unstructured":"Alger, H. M. et al. The role of TRAIL in mediating autophagy in myositis skeletal muscle: a potential nonimmune mechanism of muscle damage. Arthritis Rheum. 63, 3448\u20133457 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR156","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/j.1749-6632.2009.04812.x","volume":"1173","author":"B De Paepe","year":"2009","unstructured":"De Paepe, B., Creus, K. K., Martin, J. J., Weis, J. & De Bleecker, J. L. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages. Ann. NY Acad. Sci. 1173, 463\u2013469 (2009).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrrheum201848_CR157","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1096\/fj.09-144782","volume":"24","author":"C Grundtman","year":"2010","unstructured":"Grundtman, C. et al. Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies. FASEB J. 24, 570\u2013578 (2010).","journal-title":"FASEB J."},{"key":"BFnrrheum201848_CR158","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1002\/art.20220","volume":"50","author":"AK Ulfgren","year":"2004","unstructured":"Ulfgren, A. K. et al. Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids. Arthritis Rheum. 50, 1586\u20131594 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR159","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1136\/annrheumdis-2012-202207","volume":"72","author":"M Zong","year":"2013","unstructured":"Zong, M. et al. TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis. Ann. Rheum. Dis. 72, 1390\u20131399 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201848_CR160","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrrheum.2011.222","volume":"8","author":"HE Harris","year":"2012","unstructured":"Harris, H. E., Andersson, U. & Pisetsky, D. S. HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat. Rev. Rheumatol. 8, 195\u2013202 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum201848_CR161","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.intimp.2016.10.009","volume":"41","author":"Z Wan","year":"2016","unstructured":"Wan, Z. et al. TLR4-HMGB1 signaling pathway affects the inflammatory reaction of autoimmune myositis by regulating MHC-I. Int. Immunopharmacol. 41, 74\u201381 (2016).","journal-title":"Int. Immunopharmacol."},{"key":"BFnrrheum201848_CR162","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10974-015-9411-7","volume":"36","author":"K Cseri","year":"2015","unstructured":"Cseri, K. et al. HMGB1 expression and muscle regeneration in idiopathic inflammatory myopathies and degenerative joint diseases. J. Muscle Res. Cell. Motil. 36, 255\u2013262 (2015).","journal-title":"J. Muscle Res. Cell. Motil."},{"key":"BFnrrheum201848_CR163","doi-asserted-by":"publisher","first-page":"e0161436","DOI":"10.1371\/journal.pone.0161436","volume":"11","author":"X Shu","year":"2016","unstructured":"Shu, X., Peng, Q., Lu, X. & Wang, G. HMGB1 may be a biomarker for predicting the outcome in patients with polymyositis \/dermatomyositis with interstitial lung disease. PLoS ONE 11, e0161436 (2016).","journal-title":"PLoS ONE"},{"key":"BFnrrheum201848_CR164","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/acn3.419","volume":"4","author":"CW Keller","year":"2017","unstructured":"Keller, C. W., Schmidt, J. & Lunemann, J. D. Immune and myodegenerative pathomechanisms in inclusion body myositis. Ann. Clin. Transl Neurol. 4, 422\u2013445 (2017).","journal-title":"Ann. Clin. Transl Neurol."},{"key":"BFnrrheum201848_CR165","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00401-009-0511-6","volume":"117","author":"G Vattemi","year":"2009","unstructured":"Vattemi, G. et al. Amyloid-\u03b242 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis. Acta Neuropathol. 117, 569\u2013574 (2009).","journal-title":"Acta Neuropathol."},{"key":"BFnrrheum201848_CR166","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.bbadis.2014.09.005","volume":"1852","author":"V Askanas","year":"2015","unstructured":"Askanas, V., Engel, W. K. & Nogalska, A. Sporadic inclusion-body myositis: a degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy. Biochim. Biophys. Acta 1852, 633\u2013643 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrrheum201848_CR167","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.bbadis.2015.01.002","volume":"1852","author":"V Askanas","year":"2015","unstructured":"Askanas, V. & King Engel, W. Update on neuromuscular diseases: pathology and molecular pathogenesis. Biochim. Biophys. Acta 1852, 561\u2013562 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrrheum201848_CR168","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1136\/jnnp.2009.174276","volume":"80","author":"IE Muth","year":"2009","unstructured":"Muth, I. E., Barthel, K., Bahr, M., Dalakas, M. C. & Schmidt, J. Pro-inflammatory cell stress in sporadic inclusion body myositis: overexpression of \u03b1B-crystallin is associated with amyloid precursor protein and accumulation of \u03b1-amyloid. J. Neurol. Neurosurg. Psychiatry 80, 1344\u20131349 (2009).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrrheum201848_CR169","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.nmd.2006.08.009","volume":"16","author":"S Wojcik","year":"2006","unstructured":"Wojcik, S., Engel, W. K., McFerrin, J., Paciello, O. & Askanas, V. A\u03b2PP-overexpression and proteasome inhibition increase \u03b1B-crystallin in cultured human muscle: relevance to inclusion-body myositis. Neuromuscul. Disord. 16, 839\u2013844 (2006).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrrheum201848_CR170","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1212\/WNL.54.5.1033","volume":"54","author":"BL Banwell","year":"2000","unstructured":"Banwell, B. L. & Engel, A. G. \u03b1B-crystallin immunolocalization yields new insights into inclusion body myositis. Neurology 54, 1033\u20131041 (2000).","journal-title":"Neurology"},{"key":"BFnrrheum201848_CR171","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41467-017-00088-4","volume":"8","author":"P Wang","year":"2017","unstructured":"Wang, P., Wander, C. M., Yuan, C. X., Bereman, M. S. & Cohen, T. J. Acetylation-induced TDP-43 pathology is suppressed by an HSF1-dependent chaperone program. Nat. Commun. 8, 82 (2017).","journal-title":"Nat. Commun."},{"key":"BFnrrheum201848_CR172","doi-asserted-by":"publisher","first-page":"331ra41","DOI":"10.1126\/scitranslmed.aad4583","volume":"8","author":"M Ahmed","year":"2016","unstructured":"Ahmed, M. et al. Targeting protein homeostasis in sporadic inclusion body myositis. Sci. Transl. Med. 8, 331ra41 (2016).","journal-title":"Sci. Transl. Med."},{"key":"BFnrrheum201848_CR173","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.2353\/ajpath.2010.100050","volume":"177","author":"A Nogalska","year":"2010","unstructured":"Nogalska, A., D'Agostino, C., Terracciano, C., Engel, W. K. & Askanas, V. Impaired autophagy in sporadic inclusion-body myositis and in endoplasmic reticulum stress-provoked cultured human muscle fibers. Am. J. Pathol. 177, 1377\u20131387 (2010).","journal-title":"Am. J. Pathol."},{"key":"BFnrrheum201848_CR174","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/nan.12038","volume":"39","author":"M Cacciottolo","year":"2013","unstructured":"Cacciottolo, M., Nogalska, A., D'Agostino, C., Engel, W. K. & Askanas, V. Chaperone-mediated autophagy components are upregulated in sporadic inclusion-body myositis muscle fibres. Neuropathol. Appl. Neurobiol. 39, 750\u2013761 (2013).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BFnrrheum201848_CR175","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/ana.21115","volume":"61","author":"JD Lunemann","year":"2007","unstructured":"Lunemann, J. D. et al. Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis. Ann. Neurol. 61, 476\u2013483 (2007).","journal-title":"Ann. Neurol."},{"key":"BFnrrheum201848_CR176","doi-asserted-by":"publisher","first-page":"5470831","DOI":"10.1155\/2017\/5470831","volume":"2017","author":"K Schmidt","year":"2017","unstructured":"Schmidt, K. et al. IL-1\u03b2-induced accumulation of amyloid: macroautophagy in skeletal muscle depends on ERK. Mediators Inflamm. 2017, 5470831 (2017).","journal-title":"Mediators Inflamm."},{"key":"BFnrrheum201848_CR177","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.nmd.2016.12.009","volume":"27","author":"S Nakano","year":"2017","unstructured":"Nakano, S., Oki, M. & Kusaka, H. The role of p62\/SQSTM1 in sporadic inclusion body myositis. Neuromuscul. Disord. 27, 363\u2013369 (2017).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrrheum201848_CR178","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.4161\/auto.28479","volume":"10","author":"AS Nicot","year":"2014","unstructured":"Nicot, A. S. et al. Phosphorylation of NBR1 by GSK3 modulates protein aggregation. Autophagy 10, 1036\u20131053 (2014).","journal-title":"Autophagy"},{"key":"BFnrrheum201848_CR179","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00401-011-0874-3","volume":"122","author":"C D'Agostino","year":"2011","unstructured":"D'Agostino, C., Nogalska, A., Cacciottolo, M., King Engel, W. & Askanas, V. Abnormalities of NBR1, a novel autophagy-associated protein, in muscle fibers of sporadic inclusion-body myositis. Acta Neuropathol. 122, 627 (2011).","journal-title":"Acta Neuropathol."},{"key":"BFnrrheum201848_CR180","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s40478-016-0384-6","volume":"4","author":"S Duleh","year":"2016","unstructured":"Duleh, S., Wang, X., Komirenko, A. & Margeta, M. Activation of the Keap1\/Nrf2 stress response pathway in autophagic vacuolar myopathies. Acta Neuropathol. Commun. 4, 115 (2016).","journal-title":"Acta Neuropathol. Commun."},{"key":"BFnrrheum201848_CR181","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02481453 (2017)."},{"key":"BFnrrheum201848_CR182","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1212\/01.wnl.0000192127.63013.8d","volume":"66","author":"A Oldfors","year":"2006","unstructured":"Oldfors, A. et al. Mitochondrial abnormalities in inclusion-body myositis. Neurology 66, S49\u2013S55 (2006).","journal-title":"Neurology"},{"key":"BFnrrheum201848_CR183","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1042\/CS20160080","volume":"130","author":"M Catal\u00e1n-Garc\u00eda","year":"2016","unstructured":"Catal\u00e1n-Garc\u00eda, M. et al. Mitochondrial DNA disturbances and deregulated expression of oxidative phosphorylation and mitochondrial fusion proteins in sporadic inclusion body myositis. Clin. Sci. 130, 1741\u20131751 (2016).","journal-title":"Clin. Sci."},{"key":"BFnrrheum201848_CR184","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/nan.12149","volume":"41","author":"KA Rygiel","year":"2015","unstructured":"Rygiel, K. A. et al. Mitochondrial and inflammatory changes in sporadic inclusion body myositis. Neuropathol. Appl. Neurobiol. 41, 288\u2013303 (2015).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BFnrrheum201848_CR185","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1016\/j.jocn.2014.05.051","volume":"21","author":"PR Joshi","year":"2014","unstructured":"Joshi, P. R. et al. Functional relevance of mitochondrial abnormalities in sporadic inclusion body myositis. J. Clin. Neurosci. 21, 1959\u20131963 (2014).","journal-title":"J. Clin. Neurosci."},{"key":"BFnrrheum201848_CR186","doi-asserted-by":"publisher","first-page":"20534","DOI":"10.1074\/jbc.M112.359588","volume":"287","author":"S Boncompagni","year":"2012","unstructured":"Boncompagni, S. et al. Mitochondrial dysfunction in skeletal muscle of amyloid precursor protein-overexpressing mice. J. Biol. Chem. 287, 20534\u201320544 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum201848_CR187","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1073\/pnas.93.3.1314","volume":"93","author":"V Askanas","year":"1996","unstructured":"Askanas, V. et al. Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle. Proc. Natl Acad. Sci. USA 93, 1314\u20131319 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrrheum201848_CR188","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1093\/brain\/aws046","volume":"135","author":"J Schmidt","year":"2012","unstructured":"Schmidt, J. et al. Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1\u03b2-induced accumulation of \u03b2-amyloid and cell death. Brain 135, 1102\u20131114 (2012).","journal-title":"Brain"},{"key":"BFnrrheum201848_CR189","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/brain\/123.2.374","volume":"123","author":"P Baron","year":"2000","unstructured":"Baron, P. et al. Synergistic effect of \u03b2-amyloid protein and interferon gamma on nitric oxide production by C2C12 muscle cells. Brain 123, 374\u2013379 (2000).","journal-title":"Brain"},{"key":"BFnrrheum201848_CR190","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1002\/art.38180","volume":"65","author":"S Rayavarapu","year":"2013","unstructured":"Rayavarapu, S. et al. Activation of the ubiquitin proteasome pathway in a mouse model of inflammatory myopathy: a potential therapeutic target. Arthritis Rheum. 65, 3248\u20133258 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201848_CR191","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1097\/BOR.0000000000000119","volume":"26","author":"LG Rider","year":"2014","unstructured":"Rider, L. G., Danko, K. & Miller, F. W. Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research. Curr. Opin. Rheumatol. 26, 724\u2013741 (2014).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum201848_CR192","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/BOR.0000000000000327","volume":"28","author":"O Molberg","year":"2016","unstructured":"Molberg, O. & Dobloug, C. Epidemiology of sporadic inclusion body myositis. Curr. Opin. Rheumatol. 28, 657\u2013660 (2016).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum201848_CR193","doi-asserted-by":"publisher","first-page":"e000342","DOI":"10.1136\/rmdopen-2016-000342","volume":"2","author":"SB Helmers","year":"2016","unstructured":"Helmers, S. B. et al. Inflammatory lung disease a potential risk factor for onset of idiopathic inflammatory myopathies: results from a pilot study. RMD Open 2, e000342 (2016).","journal-title":"RMD Open"},{"key":"BFnrrheum201848_CR194","first-page":"2170","volume":"294","author":"G Mamyrova","year":"2005","unstructured":"Mamyrova, G., Rider, L. G., Haagenson, L., Wong, S. & Brown, K. E. Parvovirus B19 and onset of juvenile dermatomyositis. JAMA 294, 2170\u20132171 (2005).","journal-title":"JAMA"}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2018.48.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2018.48","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrrheum.2018.48","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2018.48.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T01:06:43Z","timestamp":1720228003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2018.48"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,20]]},"references-count":194,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["BFnrrheum201848"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2018.48","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,20]]},"assertion":[{"value":"20 April 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}